Category: Other Apoptosis

Other Apoptosis

Another enteric virus, reovirus, also showed decreased infection in pIgR KO mice

May 5, 2025 by bakingandbakingscience 0 Comments

Another enteric virus, reovirus, also showed decreased infection in pIgR KO mice. pathogenesis. KEYWORDS:RNA virus, enteric viruses, gastrointestinal infection, pathogenesis == ABSTRACT == Noroviruses are enteric pathogens causing significant morbidity, mortality, and economic losses worldwide. Secretory immunoglobulins (sIg) are a first line of mucosal defense against enteric pathogens. They are secreted into the intestinal lumen via the polymeric immunoglobulin receptor (pIgR), where they bind to antigens. However, whether natural sIg protect against norovirus infection remains unknown. To determine if natural sIg alter murine norovirus (MNV) pathogenesis, we infected pIgR knockout Rabbit Polyclonal to SRPK3 (KO) mice, which lack sIg in mucosal secretions. Acute MNV infection was significantly reduced in pIgR KO mice compared to controls, despite increased MNV target cells in the Peyer’s patch. Natural sIg did not alter MNV binding to the follicle-associated epithelium (FAE) or crossing of the FAE into the lymphoid follicle. Instead, naive pIgR KO mice had enhanced levels of the antiviral inflammatory molecules interferon gamma (IFN-) and inducible nitric oxide synthase (iNOS) in the ileum compared to controls. Strikingly, depletion of the intestinal microbiota in pIgR KO and control mice resulted in comparable IFN- and iNOS levels, as well as MNV infectious titers. IFN- treatment of wild-type (WT) mice and neutralization of IFN- in pIgR KO mice modulated MNV titers, implicating the antiviral cytokine in the phenotype. Reduced gastrointestinal infection in pIgR KO mice was also observed with another enteric virus, reovirus. Collectively, our findings suggest that natural sIg are not protective during enteric virus infection, but rather, that sIg promote enteric viral infection through alterations in microbial immune responses. IMPORTANCEEnteric virus, such as norovirus, infections cause significant morbidity and mortality worldwide. However, direct antiviral infection prevention strategies are limited. Blocking host entry and initiation of infection provides an established avenue for intervention. Here, we investigated the role of the polymeric immunoglobulin receptor (pIgR)-secretory immunoglobulin (sIg) cycle during enteric virus infections. The innate immune functions of sIg (agglutination, immune exclusion, neutralization, and expulsion) were not required during control of acute murine norovirus (MNV) infection. Instead, lack of pIgR resulted in increased IFN- levels, which contributed to reduced MNV titers. Another enteric virus, reovirus, also showed decreased infection in pIgR KO mice. Collectively, our data point to a model in which sIg-mediated microbial sensing promotes norovirus and reovirus infection. These data provide the first evidence of the proviral role of natural sIg during enteric virus infections and provide another example of how intestinal bacterial communities indirectly influence MNV pathogenesis. GO6983 == INTRODUCTION == The mucosal surface of the gastrointestinal (GI) tract is a potential entry point for many pathogens. To protect itself from pathogen attack, the host has evolved multiple mechanisms, including the secretion of immunoglobulins, i.e., secretory immunoglobulins (sIg). sIg neutralize microorganisms in the intestinal lumen and reduce the immunogenicity of the remaining bacteria (1). Intestinal epithelial cells transcytose polymeric IgA (pIgA) and pIgM from the lamina propria via the basolaterally expressed polymeric immunoglobulin receptor (pIgR). Once the pIgR-pIgA/M complex reaches the intestinal lumen, the receptor is cleaved, and sIgA GO6983 and sIgM are released (1). Pathogens that have crossed the epithelial barrier and those present in intestinal epithelial cells can also be expelled by this transcytotic process (2). Highlighting the defense function of the process are studies demonstrating that deletion of pIgR results in increased pathogen loads forHelicobacter pylori(3),Giardia muris(4),Salmonellaspp. (5), andClostridium difficile(6). sIgA are the predominant species of immunoglobulins in the intestine (7). In addition to their host defense function, they also play an immunomodulatory role (7). The follicle-associated epithelium (FAE) of Peyers patches (PP) and other mucosa-associated lymphoid follicles contain transcytotic microfold (M) cells. sIgA aid in luminal sampling and the initiation of mucosal immune responses. Selective adherence of luminal sIgA to the M cell surface triggers uptake of sIgA immune complexes into the PP (8), resulting in retrograde sIgA sampling by dendritic cells (DC) (9), noninflammatory activation of DC, and induction of regulatory T cells (7). The sIgA-induced antipathogenic immune responses also nonspecifically reduce the inflammatory potential of macrophages via upregulation of inhibitory receptors (10). Noroviruses (NoV) are the leading cause of acute gastroenteritis worldwide (11,12). Targeting host entry and infection initiation may provide an avenue for intervention, as they are instrumental in determining host range, initiation of immune responses, and pathogenesis. However, limited information is available about factors that promote or inhibit norovirus infection. To gain a better understanding of the early events during norovirus infection in GO6983 a natural host, we took advantage of murine norovirus (MNV), a well-established and highly tractable animal.

Other Apoptosis

The Align and CLUSTALO programs of Uniprot website (http://www

Mar 3, 2025 by bakingandbakingscience 0 Comments

The Align and CLUSTALO programs of Uniprot website (http://www.uniprot.org/) were also used for more precise and accurate alignments. neutralising antibodies against the pandemic strain, but also induced cross-neutralising antibodies in a subset of subjects against an UDM-001651 H1N1 strain (structural modeling approach to better understand the unusual behavior of the novel hemagglutinin, thereby demonstrating the power of computational modeling approaches for rapid characterization of new pandemic viruses. While challenges remain in ensuring ultrafast vaccine access for the entire population in response to future pandemics, the adjuvanted recombinant Panblok-H1/Advax vaccine proved its utility during a real-life pandemic situation. KEYWORDS: adjuvant, Advax, baculovirus, delta inulin, influenza, pandemic, recombinant, vaccine Introduction Seasonal and pandemic influenza vaccines have traditionally been made from inactivated virus grown in embryonated eggs. However, this approach has several limitations including developing delays while vaccine seed viruses are egg-adapted and insecurity of egg supply with potential of supply disruption if pandemic disease also infects chicken flocks. Egg-based vaccines may also not become suitable for individuals with severe egg allergies.1 Despite more recent development of large-scale facilities for mammalian cell tradition of influenza disease,2 this remains susceptible to delays while seed viruses suitable for cell tradition are generated and screened. The predictability and rate of recombinant protein manufacture are major advantages for vaccine production. A potentially more reliable approach to pandemic vaccine production, therefore, is the use of recombinant hemagglutinin (rHA). Protecting neutralising antibodies to HA are seen after influenza illness or immunization.3,4 The US government awarded contracts to a range of vaccine companies UDM-001651 including Protein Sciences Corporation (PSC), Medicago, Novovax, Fraunhofer Institute, and Vaxinnate to produce recombinant influenza vaccines using various techniques.5 PSC pioneered the use of the baculovirus expression system to produce influenza vaccine based on rHA (Flublok?), which was licensed from the FDA in 2013 for seasonal influenza safety in adults.6 The pandemic variant of this rHA TSPAN11 vaccine is known as Panblok?. While Panblok safeguarded parrots against lethal H5 or H7 illness,7 only low levels of seroprotection were obtained in human being subjects indicating the need for an adjuvant.8 While many adjuvants have been described, very few possess progressed as formulations for licensed human being vaccines.9 Advax? is definitely a novel polysaccharide adjuvant based on UDM-001651 particles of semi-crystalline delta inulin, development of which was supported through the US. National Institutes of Health’s Adjuvant Development System.10 In animal models, Advax? adjuvant offers been shown to enhance the immunogenicity of vaccines against a wide range UDM-001651 of diseases including influenza,11-13 hepatitis B,14 SARS coronavirus,15 Japanese encephalitis,16 Western Nile disease,17 RSV,18 anthrax,19 Listeria,20 HIV21 and Peste de petit ruminants. 22 Although its mechanism of action offers yet to be fully identified, Advax particles bind directly to human being monocytes and enhance their co-stimulatory function.23 Inside a pandemic influenza study in the ferret model, Advax significantly enhanced safety afforded by an inactivated H5N1 vaccine providing 100% survival versus only 66% survival seen with the standard H5N1 vaccine alone.24 The vaccine with Advax adjuvant provided over 3-fold antigen dose-sparing while significantly reducing neurologic disease and viral shedding. Notably, Advax offers been shown to be safe and immune-enhancing in humans when formulated in hepatitis B, 25 seasonal influenza26 and allergy,27 vaccines. The 2009 2009 influenza pandemic caused by the sudden emergence in UDM-001651 North America of the H1N1/2009pdm strain (originally referred to as swine flu) offered a real-life opportunity to test novel pandemic vaccine methods. It was 1st recognized in North America in April 2009 and spread rapidly around the world, leading to a declaration from the World Health Corporation of a global pandemic on June 11, 2009.28 The new influenza virus was at least as contagious as seasonal influenza and spread quickly, particularly among younger people. Some degree of pre-existing immunity was seen in older adults especially those aged over 60, probably due to earlier exposure to antigenically related influenza A viruses. Recent seasonal influenza.

Other Apoptosis

?(Fig

Oct 6, 2021 by bakingandbakingscience 0 Comments

?(Fig.1a,1a, ?a,1b).1b). differentiation. In this study, we examined the effects of NAMPT inhibition among multiple time points of cardiomyocyte differentiation. Overall, these studies show that in vitro cardiomyogenic commitment and continued culturing provides resistance to NAMPT inhibition and cell survival is associated with the ability to maintain cellular ATP pools despite depletion of NAD levels. Unlike cells at earlier stages of differentiation, day 28 hPSC\CM can survive longer periods of NAMPT inhibition and maintain ATP generation by glycolysis and/or mitochondrial respiration. This is unique from terminally StemRegenin 1 (SR1) differentiated fibroblasts, which maintain mitochondrial respiration during NAMPT inhibition. Overall, these results provide new mechanistic insight into how regulation of cellular NAD and energy pools switch with hPSC\CM differentiation and further inform how NAMPT inhibition strategies could be implemented within the context of cardiomyocyte differentiation. Stem Cells Translational Medicine test was performed when comparing treatments within a Rabbit Polyclonal to TRERF1 cell type. For comparisons among time points and treatment groups, unpaired, two\way ANOVA was performed. All ANOVA calculations were performed with multiple comparisons using Tukey post hoc test. All statistics were analyzed using GraphPad Prism version 6.07. Results Survival During NAMPT Inhibition Increases with Cardiomyocyte Differentiation and Maturation To determine when cardiomyocyte differentiation alters susceptibility to NAMPT inhibition, cells were treated with NAMPT inhibitors, STF\31 or FK866, constantly for 72 hours beginning on day 0 (confluent monolayer of hiPSC), day 5 (committed cardiac progenitors), day 10 (committed cardiomyocytes that spontaneously contract), and day 28 (time point by which cells show increased oxidative phosphorylation from option substrates 21 and adopt a more elongated mitochondrial morphology as compared to day 10 cells (Supporting Information Fig 2) and 18, 23, 33). Cell viability under NAMPT inhibition was assessed by neutral reddish uptake (an indirect assay of ATP levels) and SYTOX cell death assay (dependent on cell membrane permeability). Consistent with our previous studies 16, 17, continuous NAMPT inhibition is usually harmful to hiPSC (Fig. ?(Fig.1a,1a, ?a,1b).1b). However, the number of cells that survive NAMPT inhibition increases with differentiation. Day 5 represents the first time in differentiation where a populace of cells survive continuous NAMPT inhibition (Fig. ?(Fig.1a,1a, ?a,1b1b and Supporting Information Fig. 3a, 3b). Although day 5 vehicle control treated hiPSC\CM and hESC display increased cell death, possibly due to addition of IWR\1 at this stage of differentiation, a populace of cells remains viable after 72 hours of NAMPT inhibition. Moreover, a pulse treatment for 24 hours with 5 M STF\31 on day 5 avoids significant toxicity (Supporting Information Fig. 4A) and does not affect the ability of these cells to continue differentiating into contracting monolayers by day 15 (Supporting Information video 1 and 2). Day 10 hiPSC\CM and hESC\CM have increased cell survival with NAMPT inhibition; however, spontaneous contraction ceases by 72 hours of treatment and increased cell death is usually observed by 96 hours (data not shown). The toxicity resulting from continuous NAMPT inhibitor treatment at day 5 and 10 is usually consistent with our previous statement 17, demonstrating that treatment with 2.5 M STF\31 for 24C48 hours did not produce adverse effects on hiPSC\CM, although measurable toxicity was observed with 72 hours treatment. Open in a separate window Physique 1 Nicotinamide phosphoribosyltransferase inhibition mediated toxicity decreases as human pluripotent stem cells differentiate and continue to mature. (A, B): Bar graphs of cell viability as measured by neutral reddish (A) or SYTOX cell death assay (B) in cultures at numerous stages of differentiation (day 0, 5, 10, StemRegenin 1 (SR1) 28) treated with 2.5 M STF\31 or 100 nM FK866 for 72 hours (C): Representative immunofluorescence staining for cardiac troponin T2 (red) and nuclei (Hoechst\blue) in passaged day 28 hiPSC\CM treated with 2.5 M STF\31 or 100 nM FK866 for 72 hours with imaging at 20 (left) and 100 (right). Bottom panel represents staining with secondary antibody only. Level bar is usually 200 m and 20 m, respectively. (D, E): Bar graphs of cell viability as measured by neutral reddish (D) or SYTOX cell death assay (E) in human dermal fibroblasts following 3\10 days StemRegenin 1 (SR1) of continuous treatment with 2.5 M STF\31 or 100 nM FK866. (F): Representative brightfield images showing fibroblast morphology at 10x following 72 hours continuous treatment with 2.5 M STF\31 or 100 nM FK866 and 24 hours recovery after washout of treatment at 72 hours. Level bar is usually 50 m. Data are represented as mean??SEM for 3\6 biological replicates in each group (the depletion.

Other Apoptosis

Within each group, changes in MR data over time were examined by using ordinary least squares linear regression analyses

Sep 10, 2021 by bakingandbakingscience 0 Comments

Within each group, changes in MR data over time were examined by using ordinary least squares linear regression analyses. in vivoClabeled MSC transplants and unlabeled control transplants were E.coli polyclonal to V5 Tag.Posi Tag is a 45 kDa recombinant protein expressed in E.coli. It contains five different Tags as shown in the figure. It is bacterial lysate supplied in reducing SDS-PAGE loading buffer. It is intended for use as a positive control in western blot experiments compared by using tests. MR data were correlated with histopathologic results. Results: In vivoClabeled MSCs demonstrated significantly higher ferumoxytol uptake compared with ex vivoClabeled cells. With electron microscopy, iron oxide nanoparticles were localized in secondary lysosomes. In vivoClabeled cells demonstrated significant T2 shortening effects in BIBW2992 (Afatinib) vitro and in vivo when they were compared with unlabeled control cells (T2 in vivo, 15.4 vs 24.4 msec; BIBW2992 (Afatinib) < .05) and could be tracked in osteochondral defects for 4 weeks. Histologic examination confirmed the presence of iron in labeled transplants and defect remodeling. Conclusion: Intravenous ferumoxytol can be used to effectively label MSCs in vivo and can be used for tracking of stem cell transplants with MR imaging. This method eliminates risks of contamination and biologic alteration of MSCs associated with ex vivoClabeling procedures. ? RSNA, 2013 Supplemental material: (1C3). The need for knee replacement is rapidly increasing, with 3.48 million expected procedures by 2030 (4). However, artificial implants are associated with potential complications, such as periprosthetic fractures, loosening, and metal sensitivity (4C6). Even in the absence of complications, the lifetime of an artificial prosthesis is limited to approximately 10 years because of wear of the implant (7C9). Cell transplants, particularly stem cellCscaffold nanocomposites, overcome these problems by providing long-term biologic restoration of joint defects (10C14). Bone marrowCderived mesenchymal stem cells (MSCs) have been established as a promising source for stem cellCmediated joint repair in a clinical setting. MSCs can be easily obtained with a bone marrow aspirate, are efficiently expanded in vitro, and can differentiate into all joint components (15C17). However, interactions between transplanted MSCs and the patients host environment are still poorly understood. To monitor successful engraftment and recognize complications such as graft failure or tumor formation, MSC therapies require in vivo tracking of the transplanted stem cells with noninvasive imaging technologies. In the past, stem cell tracking has been achieved on the basis of the concept of ex vivo contrast agent labeling (18C23). This approach requires multiple ex vivo manipulations of stem cells between their harvest and transplantation. Clinical translation of ex vivoClabeling procedures is complicated from a regulatory point of view, as these manipulations greatly enhance the risk of cell sample contamination (24), alterations in stem cell biology, or in vivo side effects from added transfection agents (25C27). Most transfection agents (Lipofectamine 2000 [Invitrogen, Carlsbad, Calif] or poly-l-lysine [Sigma-P4707; Sigma-Aldrich, St Louis, Mo]) are not U.S. Food and Drug Administration (FDA) approved (28). In addition, some ultrasmall superparamagnetic iron oxideCtransfection agent combinations have induced cytotoxic effects (29C32) or altered the stem cell biology (33). To avoid these complications, we undertook to determine whether an immediately clinically applicable approach for stem cell labeling, which would not require ex vivo manipulations of harvested cells and which would eliminate the need for transfection agents, could be used to track transplanted MSCs. Our approach relies on intravenous administration of the FDA-approved iron supplement ferumoxytol (Feraheme; Advanced BIBW2992 (Afatinib) Magnetics, Cambridge, Mass) to a stem cell donor prior to stem cell harvest from bone marrow. Ferumoxytol is composed of iron oxide nanoparticles (34), which are taken up by the reticuloendothelial system in vivo (13,35C39) and which provide a strong signal intensity effect on magnetic resonance (MR) images (13,40C42). On the basis of these properties, we postulated that intravenously injected ferumoxytol would be taken up by MSCs in bone marrow, would be retained in the cells through harvesting and ex vivo expansion, and allow for sensitive in vivo MSC detection with MR imaging after transplantation into osteochondral defects. Thus, our aim was to determine whether intravenous ferumoxytol as a clinically applicable iron supplement can be used to effectively label MSCs in vivo and can be used for tracking of stem cell transplants. Materials and Methods In Vivo MSC Labeling The study was approved by the animal care and use committee at Stanford University (Stanford, Calif). Sixteen 6C8-week-old Sprague-Dawley rats (Charles River, Wilmington, Mass) served as MSC donors: Seven rats remained untreated, while nine rats were injected intravenously with ferumoxytol (= 7) or fluorescein isothiocyanate (FITC) (Fisher Scientific, Pittsburgh,.